Literature DB >> 7470747

Mechanism of noradrenaline potentiation by prostaglandin E2 in rat mesenteric artery.

A S Adeagbo, D T Okpako.   

Abstract

1 Effects of prostaglandins E2 and F2 alpha (PGE2 and PGF2 alpha) on vasoconstrictor responses to noradrenaline (NA) and methoxamine in isolated mesenteric arteries of the rat were investigated. 2 PGE2 and to a lesser extent PGF2 alpha potentiated vasoconstrictor responses to NA and methoxamine. 3 Prior treatment with reserpine increased, and bretylium reduced, the extent of potentiation significantly. 4 NA vasoconstriction persisted for 1 h after Ca2+ was removed from the perfusing Krebs solution. Prostaglandin-induced potentiation was absent in Ca2+-free Krebs, but increased proportionately with increase in external Ca2+ concentration. 5 Vasoconstriction induced by high potassium, was not potentiated by PGE2. 6 It is concluded the PGE2 potentiates NA vasoconstriction by facilitating Ca2+ influx.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7470747      PMCID: PMC2044405          DOI: 10.1111/j.1476-5381.1980.tb10911.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  The potentiating effects of ethanol on response of aortic strips to stimulant drugs.

Authors:  S Kalsner
Journal:  J Pharm Pharmacol       Date:  1970-11       Impact factor: 3.765

2.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

3.  Some properties of prostaglandin E1 action on muscle.

Authors:  P A Khairallah; I H Page; R K Türker
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-10

4.  Effects of calcium-deficient perfusion on isolated mesenteric arteries.

Authors:  T F Burks; T S Whitacre; J P Long
Journal:  Arch Int Pharmacodyn Ther       Date:  1967-08

5.  Differential effects of calcium removal upon vascular smooth muscle contraction induced by norepinephrine, histamine and potassium.

Authors:  P M Hudgins; G B Weiss
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

6.  Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta.

Authors:  S Kalsner
Journal:  Circ Res       Date:  1969-03       Impact factor: 17.367

7.  Methoxamine as a tool to assess the importance of intraneuronal uptake of l-norepinephrine in the cat's nictitating membrane.

Authors:  U Trendelenburg; R A Maxwell; S Pluchino
Journal:  J Pharmacol Exp Ther       Date:  1970-03       Impact factor: 4.030

8.  Potentiation of responses to histamine in aortic strips by steroids.

Authors:  S Kalsner
Journal:  Can J Physiol Pharmacol       Date:  1970-07       Impact factor: 2.273

9.  Inactivation of prostaglandins by the lungs.

Authors:  P J Piper; J R Vane; J H Wyllie
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

10.  Effects of a haloalkylamine on responses to and disposition of sympathomimetic amines.

Authors:  S Kalsner; M Nickerson
Journal:  Br J Pharmacol       Date:  1969-03       Impact factor: 8.739

View more
  4 in total

1.  Inhibition of vasoconstriction to cirazoline by calcium-entry blockade after phenoxybenzamine in rat perfused hindquarters.

Authors:  C Korstanje; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-10       Impact factor: 3.000

2.  Cyclo-oxygenase inhibitors antagonize indirectly evoked contractions of the guinea-pig isolated ileum by inhibiting acetylcholine release.

Authors:  D T Okpako; Y O Taiwo
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

3.  Restoration of vasoconstrictor responses to noradrenaline by prostaglandin E2 after alpha-adrenoceptor blockade in rat isolated mesenteric artery.

Authors:  A S Adeagbo; D T Okpako
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

4.  Non-competitive antagonism of the alpha-adrenoceptor-mediated fast component of contraction of rat aorta, by doxazosin and prazosin.

Authors:  O A Downing; K A Wilson; V G Wilson
Journal:  Br J Pharmacol       Date:  1983-10       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.